Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a

Appoints Daniel Finke to Group President, Markets and Commercial and Wellcare CEO Michael Carson to Group President, Medicare and Specialty  ST. LOUIS, April 6, 2026 /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4657168-1&amp;h=4273311088&amp;u=https%3A%2F%2Fwww.centene.com%2F&amp;a=Centene+Corporation" target="_blank" rel="nofollow">Centene Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/CNC">CNC</a>), a leading healthcare enterprise committed to helping people live healthier lives, today announced the creation of two new executive leadership positions, which will report to Chief Executive Officer Sarah London. Centene has hired Daniel Finke as Group President, Markets and Commercial, and appointed Michael Carson to Group President, Medicare and Specialty.
 <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/2949891/Dan_Finke_Headshot_Centene_Corporation.html" target="_blank" rel="nofollow">
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/2949891/Dan_Finke_Headshot_Centene_Corporation.jpg" title="Daniel Finke, Centene&#39;s Group President, Markets and Commercial" alt="Daniel Finke, Centene&#39;s Group President, Markets and Commercial"></img>
 </a>
 
 </div>
&#34;We are pleased to recognize Michael&#39;s continued leadership and excited to leverage Dan&#39;s deep industry expertise and track record of strategic execution,&#34; said Sarah London, Chief Executive Officer of Centene. &#34;Their collective experience will be instrumental as we continue to strengthen performance across the portfolio and deliver sustainable, profitable growth.&#34; Finke, a seasoned healthcare executive with more than two decades of experience leading and scaling complex health plan organizations across government and commercial markets, will oversee the Medicaid and Commercial segments. He joins Centene from Convey Health Solutions, where he served as Chief Executive Officer. Prior to joining Convey, he was Executive Vice President of CVS Health and President of Aetna, leading strategy and operations spanning Medicare, Medicaid, and Commercial insurance businesses. &#34;I am excited to join Centene at a time of meaningful opportunity across government-sponsored healthcare and the individual market,&#34; said Finke. &#34;Centene&#39;s mission-driven focus and strong market presence position the company to deliver innovative, high-quality solutions for members, providers and government partners. I look forward to working with the leadership team to drive long-term value for our stakeholders, including by positively impacting the health of the communities we serve.&#34; As Group President, Medicare and Specialty, Michael Carson will have expanded oversight of Centene&#39;s Medicare Advantage, Medicare Part D, Duals, and Specialty businesses. Carson&#39;s experience spans nearly three decades of healthcare leadership. Prior to joining Centene in January 2024 as CEO of its Medicare business, Wellcare, Carson served as Chief Executive Officer for Bright Healthcare and Harvard Pilgrim Health Care, as well as CareAbout, a multi-specialty, value-based care delivery organization. &#34;In this expanded role, I will continue to build on the strong foundation we have established across our Medicare and specialty businesses,&#34; said Group President, Medicare and Specialty, Michael Carson. &#34;As the healthcare landscape evolves, our focus remains on improving affordability, access, and outcomes for the members we serve. In particular, we look forward to deepening our ability to provide a better, more integrated experience to those who need it most, including those who are dually eligible for Medicaid and Medicare.&#34; About Centene Corporation  <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4657168-1&amp;h=4273311088&amp;u=https%3A%2F%2Fwww.centene.com%2F&amp;a=Centene+Corporation" target="_blank" rel="nofollow">Centene Corporation</a>, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene&#39;s investor relations website, <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4657168-1&amp;h=167896011&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3987336-1%26h%3D929308036%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3952660-1%2526h%253D4143347998%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D3948775-1%252526h%25253D1899468499%252526u%25253Dhttp%2525253A%2525252F%2525252Finvestors.centene.com%2525252F%252526a%25253Dhttp%2525253A%2525252F%2525252Finvestors.centene.com%2526a%253Dhttp%25253A%25252F%25252Finvestors.centene.com%26a%3Dhttp%253A%252F%252Finvestors.centene.com&amp;a=http%3A%2F%2Finvestors.centene.com%2F" target="_blank" rel="nofollow">http://investors.centene.com/</a>.Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as &#34;believe,&#34; &#34;anticipate,&#34; &#34;plan,&#34; &#34;expect,&#34; &#34;estimate,&#34; &#34;predict,&#34; &#34;intend,&#34; &#34;seek,&#34; &#34;target,&#34; &#34;goal,&#34; &#34;potential,&#34; &#34;may,&#34; &#34;will,&#34; &#34;would,&#34; &#34;could,&#34; &#34;should,&#34; &#34;can,&#34; &#34;continue&#34; and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our expected future operating or financial performance, changes in laws and regulations, market opportunity, quality, member experience, expectations concerning pricing actions, competition and our investments. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry&#39;s actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events, or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to design and price products that are competitive and/or actuarially sound; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical costs; rate cuts, insufficient rate changes or other payment reductions or delays by government payors affecting our government businesses; the effect of social, economic, and political conditions, geopolitical events and state and federal policies, including the amount and terms of state and federal funding for government-sponsored healthcare programs, including as a result of changes in U.S. presidential administrations or Congress; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder, including the timing and terms of renewal or modification of the enhanced advance premium tax credits or program integrity initiatives that could have the effect of reducing membership or profitability of our products; unanticipated increased healthcare costs, including due to changes in consumer and provider behaviors, inflation and tariffs; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that could impact revenue and future growth; competition, including for providers, broker distribution networks, contract reprocurements and organic growth; our ability to adequately anticipate demand and timely provide for operational resources to maintain service level requirements in compliance with the terms of our contracts and state and federal regulations; our ability to comply with the terms of our contracts and state and federal regulations and our ability to effectively oversee our third-party vendors to comply with the terms of their contracts with us and state and federal regulations; our ability to manage our information systems effectively; disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third-party vendors; impairments to real estate, investments, goodwill and intangible assets; changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; our ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws; changes in macroeconomic conditions, including inflation, interest rates and volatility in the financial markets; negative public perception of the Company and the managed care industry; uncertainty concerning government shutdowns, debt ceilings or funding; tax matters; disasters, climate-related incidents, acts of war or aggression or major epidemics; changes in expected contract start dates and terms; changes in provider, broker, vendor, state federal and other contracts and delays in the timing of regulatory approval of contracts, including due to protests and our ability to timely comply with any such changes to our contractual requirements or manage any unexpected delays in regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare or other customers); the difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings or matters including, but not limited to, our ability to resolve claims and/or allegations on acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought; challenges to our contract awards; cyber-attacks or other data security incidents or our failure to comply with applicable privacy, data or security laws and regulations; the exertion of management&#39;s time and our resources, and other expenses incurred and business changes required in connection with complying with the terms of our contracts and the undertakings in connection with any regulatory, governmental, or third-party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions; losses in our investment portfolio; restrictions and limitations in connection with our indebtedness; a downgrade of our corporate family rating, issuer rating or credit rating of our indebtedness; the availability of debt and equity financing on terms that are favorable to us and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission (SEC). This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the SEC, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. 
<div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/2949890/Michael_Carson_Headshot_Centene_Corporation.html" target="_blank" rel="nofollow">
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/2949890/Michael_Carson_Headshot_Centene_Corporation.jpg" title="Michael Carson, Centene&#39;s Group President, Medicare &amp; Specialty" alt="Michael Carson, Centene&#39;s Group President, Medicare &amp; Specialty"></img>
 </a>
 
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1980988/Centene_Corporation_Logo.html" target="_blank" rel="nofollow">
 <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1980988/Centene_Corporation_Logo.jpg" title="Centene Corporation Logo (PRNewsfoto/Centene Corporation)" alt="Centene Corporation Logo (PRNewsfoto/Centene Corporation)"></img>
 </a>
 
</div>



<img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=CG26949&amp;sd=2026-04-06"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/centene-announces-new-executive-leadership-structure-302734400.html" target="_blank">https://www.prnewswire.com/news-releases/centene-announces-new-executive-leadership-structure-302734400.html</a>SOURCE Centene Corporation

Centene Announces New Executive Leadership Structure

Centene Restructures Leadership to Enhance Growth and Market Position

Centene has announced a leadership restructuring, appointing Daniel Finke and Michael Carson to key executive roles. This strategic shift aims to leverage their extensive industry experience to enhance performance across Medicaid, Medicare, and Commercial segments, potentially positioning the company for sustainable growth and improved market competitiveness.

Centene Announces New Executive Leadership Structure

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News